China State-Owned Capital Venture Investment Fund
VC Fund
Beijing, China
China State-Owned Capital Venture Investment Fund is a VC fund in Beijing focused on Manufacturing and Health Care. China State-Owned Capital Venture Investment Fund specializes in modern information technology, smart green manufacturing industries.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 76%
Last updated:
For AI agents: llms.txt
Industries China State-Owned Capital Venture Investment Fund invests in
Stages China State-Owned Capital Venture Investment Fund invests in
Countries China State-Owned Capital Venture Investment Fund invests in
Investment Focus
Industry
- Manufacturing 6 (35%)
- Health Care 4 (24%)
- Medical 3 (18%)
- Electronics 2 (12%)
- Biotechnology 2 (12%)
Stage
- Series C 5 (29%)
- Series D 4 (24%)
- Series B 3 (18%)
- Venture - Series Unknown 2 (12%)
- Series A 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Shanghai Lianfeng
|
Shanghai Lianfeng is a high-tech enterprise that manufactures gas separation and purification equipment in the direction of energy conservation and environmental protection. | $13.8M / Venture - Series Unknown / Dec 09, 2024 | |
Microclear
|
Microclear is the developer and manufacturer of medical instruments intended to enhance ophthalmology and optometry imaging services. | $13.9M / Venture - Series Unknown / Mar 25, 2024 | |
JJC TEC
|
JJC TEC is an intelligent equipment manufacturer that focuses on the R&D and technical services of intelligent drilling robots and systems in the petroleum industry. | Series E / Dec 26, 2023 | |
Orient
|
Orient belongs to the manufacturer of optoelectronic sub-devices, display devices and components, as well as other electronic devices. | Post-IPO Equity / Dec 27, 2022 | |
|
Orient
|
Orient belongs to the manufacturer of optoelectronic sub-devices, display devices and components, as well as other electronic devices. | Series C / Dec 27, 2022 | |
Saifu Pharmaceutical
|
Saifu Pharmaceutical is a preclinical CRO service provider. | $70.9M / Series D / Dec 02, 2022 | |
Safe Medical Evaluation
|
Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The coremembers of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support. | $71.2M / Series D / Dec 02, 2022 | |
Origin Quantum
|
Origin Quantum is a full-stack quantum computing company. | $147.8M / Series B / Jul 21, 2022 | |
Helmholtz
|
Helmholtz is a research and development manufacturer of automotive heat transfer transmission systems. It is dedicated to the development, production and sales of heat transfer transmission systems. It mainly provides users with new energy vehicle thermal management systems, automotive electronic systems and other products. | $39.3M / Series B / Jan 18, 2022 | |
Guoyi Quantum
|
Guoyi Quantum is a company that uses quantum precision measurement as its core technology to provide enterprises, governments, and research institutions around the world with core key devices represented by enhanced quantum sensors, scientific instruments and equipment for analysis and testing, and enable industry applications. Products andservices such as core technology solutions. The company faces the fields of advanced materials, semiconductors, quantum science, life technology, medicine and clinical research, and is committed to helping customers promote the development of technology more efficiently and explore the future of mankind. | Series C / Dec 25, 2021 | |
| See all 17 investments → | |||
Co-Investors
CICC
5 deals together
SDIC Venture Capital
3 deals together
China Fortune-Tech Capital
2 deals together
China Pacific Insurance
2 deals together
Co-Power Capital Management
2 deals together
FOF Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does China State-Owned Capital Venture Investment Fund invest in?
China State-Owned Capital Venture Investment Fund invests primarily in Manufacturing, Health Care and Medical startups, most often at Series C and Series D stage. Most of the 17 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did China State-Owned Capital Venture Investment Fund last invest?
The most recent investment recorded for China State-Owned Capital Venture Investment Fund closed in Dec 2024. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
